598 related articles for article (PubMed ID: 11395408)
41. I-proteins - a proposed switch in myotubularin function.
Clague MJ; Dove SK; Barr FA
Trends Biochem Sci; 2004 Feb; 29(2):58-61. PubMed ID: 15102431
[TBL] [Abstract][Full Text] [Related]
42. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1.
Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G
Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569
[TBL] [Abstract][Full Text] [Related]
43. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein.
Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL
Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505
[TBL] [Abstract][Full Text] [Related]
44. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
[TBL] [Abstract][Full Text] [Related]
45. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells.
Zhao H; Dupont J; Yakar S; Karas M; LeRoith D
Oncogene; 2004 Jan; 23(3):786-94. PubMed ID: 14737113
[TBL] [Abstract][Full Text] [Related]
46. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
[TBL] [Abstract][Full Text] [Related]
47. Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors.
Bianco R; Shin I; Ritter CA; Yakes FM; Basso A; Rosen N; Tsurutani J; Dennis PA; Mills GB; Arteaga CL
Oncogene; 2003 May; 22(18):2812-22. PubMed ID: 12743604
[TBL] [Abstract][Full Text] [Related]
48. Mutations of the human PTEN gene.
Bonneau D; Longy M
Hum Mutat; 2000; 16(2):109-22. PubMed ID: 10923032
[TBL] [Abstract][Full Text] [Related]
49. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
[TBL] [Abstract][Full Text] [Related]
50. Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.
Oganesian A; Poot M; Daum G; Coats SA; Wright MB; Seifert RA; Bowen-Pope DF
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7563-8. PubMed ID: 12802008
[TBL] [Abstract][Full Text] [Related]
51. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells.
Furnari FB; Huang HJ; Cavenee WK
Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298
[TBL] [Abstract][Full Text] [Related]
52. Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors.
Di Vizio D; Cito L; Boccia A; Chieffi P; Insabato L; Pettinato G; Motti ML; Schepis F; D'Amico W; Fabiani F; Tavernise B; Venuta S; Fusco A; Viglietto G
Oncogene; 2005 Mar; 24(11):1882-94. PubMed ID: 15674339
[TBL] [Abstract][Full Text] [Related]
53. The expanding role of PTEN in neoplasia: a molecule for all seasons? Commentary re: M. A. Davies, et al., Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin. Cancer Res., 8: 1904-1914, 2002.
Fernandez M; Eng C
Clin Cancer Res; 2002 Jun; 8(6):1695-8. PubMed ID: 12060605
[TBL] [Abstract][Full Text] [Related]
54. The genetic basis of Cowden's syndrome: three novel mutations in PTEN/MMAC1/TEP1.
Tsou HC; Ping XL; Xie XX; Gruener AC; Zhang H; Nini R; Swisshelm K; Sybert V; Diamond TM; Sutphen R; Peacocke M
Hum Genet; 1998 Apr; 102(4):467-73. PubMed ID: 9600246
[TBL] [Abstract][Full Text] [Related]
55. PTEN: one gene, many syndromes.
Eng C
Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
[TBL] [Abstract][Full Text] [Related]
56. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.
Myers MP; Stolarov JP; Eng C; Li J; Wang SI; Wigler MH; Parsons R; Tonks NK
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9052-7. PubMed ID: 9256433
[TBL] [Abstract][Full Text] [Related]
57. Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman JG; Bose S; Wang SI; Parsons R; Sidransky D
Oncogene; 1998 Jun; 16(24):3215-8. PubMed ID: 9671402
[TBL] [Abstract][Full Text] [Related]
58. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
[TBL] [Abstract][Full Text] [Related]
59. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
Steelman LS; Bertrand FE; McCubrey JA
Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
[TBL] [Abstract][Full Text] [Related]
60. PTEN: The down side of PI 3-kinase signalling.
Leslie NR; Downes CP
Cell Signal; 2002 Apr; 14(4):285-95. PubMed ID: 11858936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]